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Abstract 
The analysis of biochemical blood indices is essential for testing the bioequivalence and drug 
bioavailability. The purpose of this study is to analyze the relevance of the metabolic profile as an indicator of health on 
a sheep sample and the bioequivalence testing of two anthelmintic products in view of interchanging them in therapeutic 
practice. The research required a sample of 36 clinically healthy sheep. The sheep were selected on the premise of their 
health parameters being within the physiological, clinical and hematological indexes. One unicentric, randomized, 
cross-over with two-stage, two treatments and a pause were used in the test, including: initial screening and animal 
selection, phase I, washout, phase II, and final screening. Determination of blood biochemical indexes was performed 
during initial and final screening and consisted of blood samples (on EDTA) by automatic method, with VetScan analyzer 
and Large Animal Profile kits, including: ALP-alkaline phosphatase (U / L), AST (U / L), GGT-gamma- 
glutamyltransferase (U / L), BUN-ureic nitrogen in the blood (mmol / L), total protein (g / L), GLOB-globulins (g / L), 
Ca-calcium (mmol / L), P-phosphorus (mmol / L), Mg - Magnesium (mmol / L). The results obtained revealed significant 
oscillations of most of the biochemical blood indices, but within the physiological range of the species and age, with 
some exceptions. Deviations consisted of ALP, CK and albumin slightly rising above the upper physiological limits, 
which we associated with stress-induced manipulation. Considering that the physical effort intensifies the CK activity, 
we attribute the higher values recorded in some sheep to the muscular effort generated by the natural grazing and the 
manipulation during the test. On the other hand, the slight increases in albuminemia correlated with dehydration. The 
integration of the values obtained in the evaluation of the biochemical blood indexes in the results of the clinical, 
haematological and statistical parameters was the confirmation that the sheep's health was in accordance with the 
requirements imposed by the protocol elaborated for the bioequivalence testing of the anthelmintic products tested. 
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Introduction 
The veterinary medical therapy is currently dominated by generic drugs, which have 
become much more accessible on the market than the innovative ones (Vlase et al., 2011). Although 
generic drugs have the same therapeutic effects as the original, their cost is much lower (Crivinenu, 
2008). In the case of original drugs, the high cost is given by their newer active substance and, in 
particular, by the magnitude of pre-clinical (in vivo and in vitro) and clinical studies (phase I, II, 
III and even IV) needed for their endorsement (Vlase et al., 2011). In contrast, generic drugs assume 
the same active substances and concentrations (therapeutic doses) as the originals, however the 
excipients may be identical or different. As a consequence, studies for introducing a generic drug 
are fewer, as they only include studies for pharmaceutical development and formation, along with 
bioequivalence assessments. We also mention that the lower price does not mean a decrease in the 
quality of the product, but it is given by reduced costs with the paraclinical and clinical studies 
required for obtaining the original products (Nation and Sansom 1994; Vlase et al., 2011). 
The bioequivalence tests can also monitor the duration and intensity of the side effects. 





effects and interactions with other drugs or foods (Lainesse et al, 2012). Bioequivalence testing 
uses pharmacokinetic investigations to analyze the bioavailability of the body's influence on active 
substances, as well as pharmacodynamic investigations to evaluate the mechanism, area of action, 
and the effects of the drug (Arion et al., 2015). Among these, metabolic profile tests are 
indispensable because they provide exhaustive information for analyzing the rate and extent of 
absorption of active molecules and the overall bioavailability of the medicinal substances required 
for bioequivalence studies. A first requirement for the success of bioequivalence studies is the 
correct serial blood sampling, which at present must comply with the rules of professional ethics 
and animal welfare (Mungiu, 1995). 
At the end of a bioequivalence study based on plasma concentration and area under the 
curve of plasma concentrations over time, absolute bioavailability, along with half-life or plasma 
clearance can also be calculated (Arion et al, 2015, Ognean et al, 2012) . The determination of the 
main blood biochemical indices is necessary and decisive for the analysis and evaluation of 
bioequivalence and drug bioavailability (Trepanier, 2013). 
The main aim of the research undertaken in this study is focused on the relevance of 
metabolic profile analyzes in assessing the health of a sample of sheep, which was tested for the 
bioequivalence of two anthelmintic products based on Triclabendazole and Ivermectin, active 
molecules with major impact in veterinary medicine therapy. 
 
Method and materials 
The major objective of the research was focused on the correlation of blood biochemical 
indexes with relevance to drug pharmacokinetics testing, being an integral part of the protocol used 
to test the bioequivalence of two anthelmintic drugs, Ivermectin and Triclabendazole. 
The location of the researches was done in a private sheep micro farm in Hunedoara 
County and the FMV Cluj-Napoca laboratories and the Vim Spectrum Clinical and Analytical 
Research Center. 
The animals that participated in the study were of Turcana sheep breed. In accordance 
with the inclusion / exclusion criteria, a sample of clinically healthy ovine (n = 36), one year old, 
non-pregnant and non-lactating, was selected, including 26 females and 10 males. The sheep were 
selected 7 days before the start of the study, based on their fitting into physiological limits and 
according to clinical and hemato-biochemical health indices as well as the requirements specified 
in the inclusion / exclusion criteria. Animal feed was predominantly based on high quality hay and 
grain maize, and water would be administered at discretion throughout the test. Feed restrictions 
have been imposed only during drug administration days, consisting of suspending the feed 
throughout the day, and the water 2 hours before and 2 hours after the administration of the 
products. 
The testing followed a unicentric, randomized, cross-over protocol with two sequences, 
two treatments and a pause between them. The protocol used was adapted to evaluate the 
bioequivalence of anthelmintic products with two types of active molecules on sheep as the target 
species, and its use went through the initial screening and animal selection, Phase I, washout phase, 
Phase II and final screening. 
The initial screening was performed during the pre-test week and was completed by 
selecting the sample of healthy animals for the testing. 
Phase I included: organizing the study (day 0), testing, including obtaining the first blood 





with blood sampling and clinical evaluation for the next 15 time intervals (days 2-20). Phase II the 
activities from the first phase were repeated. The washout period was set at 14 days. 
The final examinations were performed at the end of the second phase, including 
repeating the clinical and para clinical examinations. 
Serial blood sampling was performed on EDTA under identical conditions during the 
two phases of the study, strictly following the protocol steps. For this purpose, we have resorted to 
the catheterization and puncture of the peripheral veins, with 18 G needles and butterfly needles, 
which were very well accepted by the sheep, the sample label clearly identifying the code and the 
phase of the study, the animal identification number and the harvest time period. 
The processing and analysis of the blood samples included two sets of investigations. 
The first consisted of the analysis of clinical and paraclinical (haemato-biochemical, urinary) 
indices in the selected and tested animals (initial screening) and their evolution at the end of the 
test (final screening). The second included plasma separation (centrifuged 10 minutes at 2000 
RPM) and their analysis for the determination of the concentration of Ivermectin and 
Triclabendazole (by UV detection method). 
The determination of metabolic profile indices was performed during initial and final 
screening, consisting of analyzing blood samples (EDTA harvested) by automatic method, with a 
VetScan type analyzer, using Large Animal Profile kits. Metabolic profile tests included the 
determination of the following blood biochemical parameters: Alkaline ALP phosphatase (U / L), 
AST-aspartate aminotransferase (U / L), GGT-gamma-glutamyl transferase (U / L) (mmol / L), 
total protein TP (g / L), ALB albumin (g / L), GLOB globulin (g / L), calcium phosphate), Mg- 
magnesium (mmol / L). 
The statistical analysis of the data included the set of parameters needed to assess the 
bioequivalence of medicinal products, including the values obtained in the processing of 
biochemical blood parameters. They were a vital part of the statistical analyzes carried out by 
applying the ANOVA system, the KINETICA program 4.4.1. and of other statistical calculations 
focused on the determination of primary parameters, such as AUC0-t (Aria under curve integrated) 
and Cmax (Peak drug concentration). 
 
Results and discussions 
The overall analysis of the recorded data revealed important individual variations in the 
values of biochemical blood indices and other parameters investigated but all within the 
physiological limits of the species and age of the studied animals (Table 1). A first explanation of 
these developments is attributed to the strict compliance with the inclusion and exclusion 
conditions set out in the bioequivalence test protocol, which outlined the selection of animals with 
a good level of health. 
The analysis of the enzyme-based indices has been focused on the essential information 
provided by them in assessing the functional status of the main systems and organs involved in 
drug metabolism. In this context, the important oscillations noted in our study, consisted of 
increases in the mean values of ALP, over the physiological limits of the species (8.9-49 U / L), 
both at the beginning of the test (169.19 U / L) and at completion (181.86 U / L), reaching a 
maximum of 274.00 U / L (Table 1 and Figure 1). Like other researchers in the field, we believe 
that these moderate alkaline phosphatase variations may be attributable to mild and ephemeral 
disorders of hepatocyte metabolic functions (Ghergariu et al., 2000; Cucuianu et al., 1996). 





a case whose abnormalities peaked at 139 U / L during the first screening and 151 U / L at the final 
screening (Fig. 1). Research on enzyme profile analyzes indicates increases in AST values in 
myocardiopathies, dietary myodistrophy and muscle trauma, inferior to other enzymes for evidence 
of hepato-biliary diseases (Ghergariu et al., 2000). Our study did not indicate significant gender 
influences on AST and ALP activity, as well as other researches in the field (Mostaghni et al., 
2005; Khan, 2013). 
It is worth mentioning some aspects of the activity of the serum GGT, which has a 
primary hepato-biliary origin, its increases being correlated with the progression of cholestasis, 
hepatic dystrophies of different origins or chronic hepatopathologies (Ghergariu et al., 2000) . In 
our study, the GGT values (46-47 U / L) were little beyond the physiological limits and thus can 
be correlated with the early evolution of a weak parasitic infestation. In this regard, there are studies 
suggesting that increases in GGT activity may be associated with a simple carrying of fasciolas in 
the bile ducts (Nseabasi et al., 2014). 
Hepatic indices analysis revealed, as expected, values within the physiological range of 
most of the tested indices (Table 1 and Figure 2). However, slight deviations were also recorded. 
This was the case with the protein, which showed average values at the upper limit or slightly 
higher of the serum albumin (38-43 g / L), which we associated with the evolution of possible cases 
of pseudoalbuminemia. Such developments may be due to the intense muscular effort associated 
with dehydration as a result of the great distances traveled daily by sheep during the pre-study 
period, when they were predominantly maintained in a natural grazing system. In this context, we 
mention that the plasma protein level is an essential factor for maintaining blood viscosity, acid- 
base balance, and is also a support for maintaining some activities of the enzyme systems (Keser 
and Bilal, 2008; Whalan, 2015). 
The overall analysis of the mean values of the total proteinemia, recorded in the initial 
and final tests, revealed that they were within the physiological ranges recorded in various 
researches in this field for the domestic ruminant species (73,31-76,70 g / L) (Kaneko, 1989). We 
also mentioned that we did not find gender differences in the mean values of albumin and globulin 
logged in the initial and final screening, similar developments being noted in Khan's research 
(2013). 
The analysis of the ionogram revealed that the average concentrations of Ca, P and Mg 
ions were maintained within the physiological spectrum, with the values recorded being very close 
between the two testing intervals. Thus, as shown in the data presented in Table 1 and in Figure 3, 
for the initial and final calcemia, the values recorded were very close, 2.49 mmol/L (with a 
minimum of 2.05 and maximum of 2.73 mmol/L) at the beginning of the serial sample harvesting 
and 2.42 mmol/L (with a minimum of 1.50 and a maximum of 2.73 mmol/L) upon completion. 
The same was the evolution of the plasma levels of phosphorus, which showed insignificant 
oscillations, with initial mean values of 2.53 mmol / L and final of 2.33 mmol / L, falling within 
the physiological limits of the species (1.30-2.40 mmol / L). Consistency was also shown by the 
blood levels of magnesium, characterized by statistically insignificant oscillations, with average 
values of 1.00 mmol / L at the beginning of the sample harvesting and of 1.10 mmol / L at the end 






Values obtained from statistical analysis of metabolic profile indices in the ovine sample 
introduced in the bioequivalence test 
Parameters/ 
References 
Initial Screening Final Screening 
Mean SD Min Max Count Mean SD Min Max Count 
ALP (UI/L)/27-156 169 38 103 274 36 182 54 98 349 36 
AST (UI/L)/49-123 111 19 55 139 36 110 25 55 151 36 
GGT (UI/L)/ 20-44 47 7 31 66 36 46 12 31 90 36 
BUN (mmol/L)/3.7- 9.3 6.3 1.6 2.9 8.8 36 4.5 1.6 1.0 8.0 36 
TP (g/L)/59-78 74 4 67 82 36 74 8 44 85 36 
ALB (g/L)/27-37 43 3 32 48 36 38 6 25 49 36 
GLOB (g/L)/32-50 32 5 24 49 36 34 6 19 49 36 
Ca (mmol/L)/2.30-2.90 2.49 0.15 2.05 2.73 36 2.42 0.25 1.50 2.73 36 
P (mmol/L)/1.30-2.40 2.53 0.41 1.99 3.67 36 2.33 0.42 1.45 3.23 36 















Figure 1. Distribution of individual and average values of ALP, AST and GGT concentrations 

































Figure 2. Distribution of individual and average values of PT, ALB, and GLOB concentrations 
in the sheep sample during the bioequivalence test; A-Initial Screening and B – Final Screening 
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Figure 3. Distribution of the individual and average values of Ca, P and Mg concentrations in the 
ovine sample during the bioequivalence test; A-Initial Screening and B – Final Screening 
 
 
From all the results obtained, it was found that the evaluation of blood biochemical 
parameters has a major impact on the health status of the animals used in the bioavailability and 
bioequivalence drug tests, their modifications revealing dysfunctions that may affect some 
pharmacokinetic and pharmacodynamic parameters. Furthermore our study continues with the 
integration of the biochemical blood values recorded into the overall clinical, haematological and 
statistical results in order to confirm that the animals used in the bioequivalence testing of the two 















We consider that the metabolic indices were of major relevance in monitoring the 
evolution of health status and changes that can have pathological connotations in sheep used in the 
bioequivalence study of the two anthelmintic products containing Ivermectin and Triclabendazole. 
The comparative analysis of the main biochemical indices during the initial and final screening 
also revealed some deviations from the physiological parameters, which lacking statistical 
significance, allowed the determination of the bioequivalence of the tested products in order to 
interchange them in anthelmintic therapy in sheep. 
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